Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Entrada Therapeutics Inc (TRDA)

NASDAQ:TRDA

US Market

TRDA

Entrada Therapeutics Inc

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Entrada Therapeutics Inc (TRDA) Stock News & Sentiment

86 Followers

Entrada Therapeutics Inc.: Promising Therapeutic Potential and Favorable Valuation Amidst Risks

Ratings

Entrada Therapeutics Inc.: Promising Therapeutic Potential and Favorable Valuation Amidst Risks

19d ago

Entrada Therapeutics Advances Duchenne Muscular Dystrophy Trial

Company Announcements

Entrada Therapeutics Advances Duchenne Muscular Dystrophy Trial

20d ago

Entrada Therapeutics’ Q3 2024 Financial Highlights

Company Announcements

Entrada Therapeutics’ Q3 2024 Financial Highlights

4M ago

Is TRDA a Buy, Before Earnings?

Pre-Earnings

Is TRDA a Buy, Before Earnings?

4M ago

Entrada Therapeutics’ Promising Phase 1 DMD Drug Trial Results

Company Announcements

Entrada Therapeutics’ Promising Phase 1 DMD Drug Trial Results

8M ago

‘Time to Pull the Trigger,’ Says Oppenheimer About These 3 Stocks

Stock Analysis & Ideas

‘Time to Pull the Trigger,’ Says Oppenheimer About These 3 Stocks

1y ago

TRDA Craters as U.S. FDA Places a Clinical Hold

Market News

TRDA Craters as U.S. FDA Places a Clinical Hold

2y ago

More TRDA News >

TRDA News on the Web

2025-02-12

Entrada Therapeutics, Inc. : A Cheap Biotech Stock to Invest In Now

Yahoo Finance

Neutral

2025-02-04

Entrada gets UK MHRA authorisation to begin Phase I/II trial of DMD treatment

Clinical Trials Arena

Neutral

2025-02-03

ENTR-601-44 Trial For DMD Authorized In UK, Study Launch Expected In Q2 2025

rttnews

Neutral

2025-02-03

Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-44-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-44 in Patients Living with Duchenne Muscular Dystrophy

Yahoo Finance

Neutral

2025-01-30

Azenta Announces the Election of Dipal Doshi to its Board of Directors

Yahoo Finance

Neutral

2024-12-30

Here's Why Encompass Health is a Smart Addition to Your Portfolio

Zacks

Neutral

2024-12-30

New Strong Buy Stocks for December 30th

Zacks

Neutral

2024-12-11

Recent Price Trend in Entrada Therapeutics (TRDA) is Your Friend, Here's Why

Zacks

Neutral

News Score - Last 7 Days

Neutral

TRDA

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week50%

Sector Average57%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TRDA’s Media Buzz Sentiment?

Currently, no data Available

What is TRDA’s weekly average amount of articles?

Currently, no data Available

What is TRDA’s News Sentiment?

50% of articles about TRDA were positive this week, compared to its sector average of 57%.

Healthcare Stocks that are Trending in the News

HCMHUTCHMED

PENPenumbra

AMNAMN Healthcare Services

BNTCBenitec Biopharma

IMUXImmunic

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing